Q2 2017 Holdings
Filed 2017-08-14 | 47 holdings | $118.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $45.5M | 500,789 | 38.2% |
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $27.5M | 990,924 | 23.1% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $17.1M | 614,200 | 14.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | Common | 09058V103 | $10.9M | 1,953,525 | 9.1% |
| Catalyst Pharmaceuticals Inc(CPRX) | Common | 14888U101 | $10.5M | 3,804,745 | 8.8% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $4.6M | 215,597 | 3.8% |
| Cellectis(CLLS) | Sponsored ADR | 15117K103 | $2.2M | 85,689 | 1.9% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $92.6K | 10,488,076 | 0.1% |
| Kite Pharma Inc | Common | 49803L109 | $83.6K | 806,750 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $59.7K | 5,930,956 | 0.1% |
| Tesaro Inc | Common | 881569107 | $56.0K | 400,403 | 0.0% |
| Medicines Co | Common | 584688105 | $42.2K | 1,109,100 | 0.0% |
| Dermira Inc(DERMEUR) | Common | 24983L104 | $38.6K | 1,325,000 | 0.0% |
| Teligent Inc | Common | 87960W104 | $37.8K | 4,130,800 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | Common | 04269X105 | $34.9K | 4,175,376 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $30.5K | 4,151,343 | 0.0% |
| Global Blood Therapeutics Inc | Common | 37890U108 | $23.5K | 860,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | Common | 695127100 | $22.2K | 465,818 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | Common | 053588109 | $14.7K | 6,632,452 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common | 921659108 | $14.7K | 902,146 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | Common | 189464100 | $13.2K | 140,700 | 0.0% |
| Assembly Biosciences Inc | Common | 045396108 | $12.5K | 607,162 | 0.0% |
| Agenus Inc(AGENEUR) | Common | 00847G705 | $12.4K | 3,183,828 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | Common | 00771V108 | $12.1K | 230,842 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | Common | 64125C109 | $10.1K | 219,500 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $8.3K | 2,275,401 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $8.2K | 5,891,581 | 0.0% |
| Veracyte Inc(VCYT) | Common | 92337F107 | $7.6K | 907,596 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | Common | 800677106 | $7.0K | 800,000 | 0.0% |
| Cascadian Therapeutics Inc | Common | 14740B606 | $6.8K | 1,821,248 | 0.0% |
| Viveve Medical Inc | Common | 92852W204 | $5.7K | 795,500 | 0.0% |
| Nevro Corp(NVROEUR) | Common | 64157F103 | $3.7K | 50,000 | 0.0% |
| Fortress Biotech Inc | Common | 34960Q109 | $2.9K | 603,657 | 0.0% |
| PTC Therapeutics(PTCT) | Common | 69366J200 | $2.2K | 120,000 | 0.0% |
| Axovant Sciences LTD | Common | G0750W104 | $1.9K | 82,087 | 0.0% |
| Pernix Therapeutics Holdings Inc | Convertible Debt | 71426VAK4 | $1.9K | $6,000,000 | 0.0% |
| Spdr S&P 500 ETFPut | Put | 78462F953 | $1.5K | 250,000 | 0.0% |
| Neuroderm LTD | Common | M74231107 | $1.3K | 44,516 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | Common | 83587F202 | $832 | 416,230 | 0.0% |
| Oncobiologics Inc | Common | 68235M105 | $684 | 683,531 | 0.0% |
| Array Biopharma Inc(ARRYEUR)Call | Common | 04269X105 | $587 | 500,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD)Call | Common | 03152W109 | $532 | 250,000 | 0.0% |
| Ovascience Inc | Common | 69014Q101 | $489 | 313,316 | 0.0% |
| Medicines CoCall | Common | 584688105 | $50 | 200,000 | 0.0% |
| Oncobiologics Inc - Warrant A | Warrant | 68235M113 | $40 | 233,333 | 0.0% |
| Oncobiologics Inc - Warrant B | Warrant | 68235M121 | $22 | 233,333 | 0.0% |